natgillin/translations-raw huggingface dataset:
To vprašanje je povezano s proizvajanjem in spremljanjem ter je bistveno za mala in srednja podjetja, ki so tesno povezana z razvojem proizvodnih postopkov.
This question concerns both manufacturing and controls and is vital to SME, which are closely involved in the development of production processes.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 1
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2, indent 1
– Vključevanje bioloških podatkov in procesov: zbiranje obsežnejših podatkov, sistemska biologija.
- Integrating biological data and processes: large-scale data gathering, systems biology.
Ustvarjanje in analiziranje obsežne količine podatkov, potrebnih za boljše razumevanje kompleksnih mrež, ki urejajo tisoče genov in genskih produktov, ki nadzorujejo pomembne biološke procese.
To generate and analyse the vast amount of data needed to understand better the complex regulatory networks of thousands of genes and gene-products controlling important biological processes.
– Vključevanje bioloških podatkov in procesov ter modelizacija zapletenih sistemov : zbiranje obsežnejših podatkov, sistemska biologija in fiziologija , prilagajanje celičnih in bioloških modelov.
-Integrating biological data and processes and modelisation of complex systems : large-scale data gathering, systems biology and physiology, engineering of cellular and biological models .
Ustvarjanje in analiziranje obsežne količine podatkov, potrebnih za boljše razumevanje kompleksnih mrež, ki urejajo tisoče genov , njihovih mutacij in genskih produktov ter celičnih sistemov , ki nadzorujejo pomembne biološke procese (tj. sinaptična in celična reorganizacija) .
To generate and analyse the vast amount of data needed to understand better the complex regulatory networks of thousands of genes, their mutations and gene-products and cell systems controlling important biological processes (i.e. synaptic and cellular reorganisation) .
Poudarek bo na genomiki, svetu RNK, proteomiki, populacijski genetiki, primerjalni in funkcionalni genomiki.
The focus will be on genomics, the RNA world, proteomics, population genetics, comparative and functional genomics.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 2
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2, indent 2
– Raziskave možganov in z njimi povezanih bolezni, človekovega razvoja in staranja.
– Research on the brain and related diseases, human development and ageing.
Raziskovanje procesa zdravega staranja in načina, kako geni in okolje medsebojno vplivajo na delovanje možganov v normalnih pogojih ter tudi v primeru možganskih bolezni .
To explore the process of healthy ageing and the way genes and environment interact with brain activity, under normal conditions as well as in brain diseases .
– Raziskave možganov in z njimi povezanih bolezni, človekovega razvoja in staranja , pri čemer je poudarek zlasti na progresivnih degenerativnih boleznih in različnih oblikah epilepsije .
– Research on the brain and related diseases, human development and ageing , focusing in particular on progressive degenerative diseases and the different forms of epilepsy .
Raziskovanje procesa zdravega staranja in izboljšanje kakovosti življenja starejših.
To explore the process of healthy ageing and improve the quality of life of elderly people.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 2 a (novo)
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2 , indent 2 a (new)
– Vedenjske značilnosti človeka.
- Human ethology.
Študija človeka ter mestnega, naravnega in kulturnega okolja.
To study man and the urban, natural and cultural environment.
Poznavanje človeka ter njegovih odzivov in prilagajanja na okolje je osnovna zahteva za razumevanje vedenja in možnih vedenjskih motenj človeka.
A knowledge of man and of his responses and adaptation to the environment is a basic requirement if his behaviour and possible dysfunctions are to be understood.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 1
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2, indent 3
– Translacijske raziskave pri nalezljivih boleznih.
– Translational research in infectious diseases.
– Translacijske raziskave pri nalezljivih boleznih in interakciji med patogeni in gostitelji .
– Translational research in infectious diseases and pathogen-host interactions .
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 4
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2, indent 4
– Translacijske raziskave na področju težkih bolezni: rak, bolezni srca in ožilja, sladkorna bolezen/debelost ; redkih bolezni in drugih kroničnih bolezni (npr. osteoartritis).
- Translational research in major diseases: cancer, cardiovascular disease, diabetes/obesity; rare diseases; and other chronic diseases (e.g. osteoarthritis).
Razvijanje strategij, usmerjenih v pacienta, od preprečevanja do postavljanja diagnoze in zdravljenja, vključno s kliničnimi raziskavami.
To develop patient-oriented strategies from prevention to diagnosis and treatment including clinical research.
– Translacijske raziskave na področju težkih bolezni: rak, bolezni srca in ožilja, alergijske bolezni in bolezni dihal; sladkorna bolezen/debelost; revmatičnih bolezni; redkih bolezni in drugih kroničnih bolezni (npr. osteoartritis).
- Translational research in major diseases: cancer, cardiovascular disease, allergic and respiratory diseases; diabetes/obesity; rheumatic diseases; rare diseases; and other chronic diseases (e.g. osteoarthritis).
Razvijanje strategij, usmerjenih v pacienta, od preprečevanja do postavljanja diagnoze in zdravljenja, vključno s kliničnimi raziskavami in raziskavami učinkovin .
To develop patient-oriented strategies from prevention to diagnosis and treatment including clinical research and research on active ingredients .
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 2, alinea 4 a, 4 b in 4 c (novo)
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 2, indents 4 a, 4 b and 4 c (new)
– Translacijske raziskave poklicnih bolezni in bolezni, ki jih povzročajo okoljski in z delom povezani stresni dejavniki, kot so astma in alergije.
- Translational research into occupational diseases and into diseases caused by environmental and work-related stress factors (such as asthma and allergies) .
Predložitev in analiza podatkov v zvezi s temi boleznimi in nesrečami pri delu ter razvoj strategij za preprečevanje, diagnosticiranje in zdravljenje (npr. v zvezi s kostno-mišičnimi boleznimi).
To produce and analyse data on these diseases and accidents at work, and develop strategies for prevention, diagnosis and treatment (e.g. for musculo-skeletal disorders).
– Translacijske raziskave zdravja uporabnikov sistemov za prevoz potnikov in bližnjih prebivalcev.
- Translational research into the health of users of passenger transport systems and nearby residents.
Študija dolgoročnih in obsežnih vplivov.
To study the long-term and large-scale effects.
– Paliativna medicina: Bolečinska terapija in simptomatska terapija pri boleznih, ki še niso ozdravljive, da se pacientu kar najbolj učinkovito lajšajo simptomi.
- Palliative medicine: pain therapy and symptomatic therapy for diseases which are not yet curable, in order to combat the patient's symptoms as effectively as possible.
Priloga I, poglavje I Sodelovanje, tema Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 1
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 1
– Prenos rezultatov kliničnih raziskav v klinično prakso .
– Translating clinical outcome into clinical practice.
Razumevanje kliničnega odločanja in načina, kako prenesti rezultate kliničnih raziskav v klinično prakso, in zlasti obravnavanje specifičnosti otrok, žensk in starejšega prebivalstva.
To understand clinical decision-making and how to translate outcomes of clinical research into clinical practice and especially addressing the specificities of children, women and elderly population.
Preučevanje naprednega računalniškega odkrivanja, podpornih sistemov za klinično odločanje in drugih orodij informacijske tehnologije za izboljšanje pretoka dela, kakovosti diagnosticiranja ter zdravljenja, za zmanjšanje zdravniških napak in stroškov, ter razumevanje kliničnega odločanja in načina, kako prenesti rezultate kliničnih raziskav v klinično prakso , in zlasti obravnavanje specifičnosti otrok, žensk , starejšega prebivalstva in invalidov .
To study advanced computer-aided detection, clinical decision support systems and other IT tools to improve workflow, enhance quality of diagnosis and treatment, reduce medical error and lower costs, as well as to understand clinical decision-making and how to translate outcomes of clinical research into clinical practice and especially addressing the specificities of children, women , the elderly population and disabled persons .
Razvoj telemedicinskih aplikacij v korist odmaknjenega prebivalstva EU, zlasti na otokih in v gorskih območjih.
To develop telemedical applications for geographically isolated populations of the European Union, especially in island and mountainous regions .
Zagotavljanje zdravstvenega varstva pogosto ne omogoča ustreznega dostopa za invalide in etnične manjšine.
Health care delivery is often not adequately designed to ensure it is properly accessed by disabled persons and ethnic minorities.
Raziskave o tem, kako zdravstveno varstvo dosega takšne prikrajšane skupine, so pomanjkljive in to področje je treba raziskati.
Research in respect of how health care reaches such disadvantaged groups is lacking and needs to be investigated .
Podporni sistemi za klinično odločanje in napredno računalniško odkrivanje lahko pomagajo obravnavati vedno bolj zapleteno medicinsko diagnosticiranje in zdravljenje.
Clinical decision support systems and advanced computer-aided detection can help handling the growing complexity of medical diagnosis and treatment.
S tem in drugim orodjem informacijske tehnologije je mogoče doseči veliko večjo učinkovitost zdravstvenega varstva v bolnišnicah in sekundarne oskrbe z izboljšanjem pretoka dela in kakovosti diagnosticiranja, povezovanjem ljudi s postopki in iztržki ter zmanjšanjem zdravniških napak in stroškov.
These and other Information Technology tools have the potential to achieve breakthroughs in the efficiency of healthcare in hospitals and secondary care by improving the workflow, enhancing the quality of diagnosis, linking people to processes and proceeds, reducing medical errors, and lowering costs.
Prebivalstvo oddaljenih evropskih regij, zlasti na otokih in v gorskih območjih, se lahko vključi v skupine prebivalstva, katerih posebnosti se za optimalizacijo zdravstvenega varstva obravnavajo posebej.
The population of remote EU regions (especially island and mountainous regions) may be included among the population groups whose specificities are to be especially addressed with a view to optimising the delivery of health care.
Cilj je podpreti telemedicinske aplikacije za odmaknjeno prebivalstvo Evropske unije.
The objective is to support tele-medical applications for remote populations in the European Union.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 2
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 2
– Kakovost, učinkovitost in solidarnost zdravstvenih sistemov, vključno z zdravstvenimi sistemi v prehodu.
– Quality, efficiency and solidarity of health systems including transitional health systems.
Prenos učinkovitih posegov v odločitve na področju upravljanja, da bi zagotovili ustrezno preskrbo s človeškimi viri, preučili dejavnike, ki vplivajo na pravico dostopa do visokokakovostnega zdravstvenega varstva, vključno s preučitvijo sprememb v populaciji (npr. staranje, mobilnost in migracije ter menjava delovnega mesta).
To translate effective interventions into management decisions, to ensure an adequate supply of human resources, to analyse factors influencing equity of access to high quality health care, including analyses of changes in population (e.g. ageing, mobility and migration, and the changing workplace).
Prenos učinkovitih posegov v odločitve na področju upravljanja , "preoblikovanje" diagnostičnih in terapevtskih postopkov , da bi zagotovili ustrezno preskrbo s človeškimi viri, preučili dejavnike, ki vplivajo na pravico dostopa do visokokakovostnega zdravstvenega varstva (tudi za zapostavljene skupine) , vključno s preučitvijo sprememb v populaciji (npr. staranje, mobilnost in migracije ter menjava delovnega mesta) in zapletov med bolnišničnim zdravljenjem .
To translate effective interventions into management decisions, to ‘re-engineer’ diagnostic and therapeutic processes, to ensure an adequate supply of human resources, to analyse factors influencing equity of access to high-quality health care ( also by disadvantaged groups ), including analyses of changes in the population (e.g. ageing, mobility and migration, and the changing workplace) and complications during hospital treatment .
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 3
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 3
Boljše preprečevanje bolezni in boljša uporaba zdravil.
Enhanced disease prevention and better use of medicines .
Razvoj učinkovitega javnozdravstvenega varstva, ki se ukvarja s širšimi determinantami zdravja (kot na primer stres, prehrana ali okoljski dejavniki) .
To develop efficient public health interventions addressing wider determinants of health (such as stress, diet or environmental factors) .
Ugotavljanje uspešnih posegov na različnih področjih delovanja zdravstvenega varstva z namenom izboljšanja predpisovanja zdravil in izboljšanja njihove uporabe s strani pacientov (vključno z vidikom farmakovigilance).
To identify successful interventions in different health care settings for improving the prescription of medicines and improving their use by patients (including pharmacovigilence aspects).
Razvoj učinkovitega javnozdravstvenega varstva, ki se ukvarja s širšimi determinantami zdravja.
To develop efficient public health interventions addressing wider determinants of health.
Zdravo okolje: analiza treh dejavnikov: sindromi in kronična izpostavljenost; interakcija strupenih snovi in mešanic takih snovi; analiza genetskih polimorfizmov in imunološki preskusi, vključno s preskusi transformacije in aktivacije limfocitov.
Environmental health : analysis of three factors: syndromes and chronic exposure; interaction with toxic substances and mixtures of such substances; analysis of genetic polymorphisms and immunology tests, including tests for lymphocyte transformation and activation.
Izvedejo se imunološke, toksikološke in epidemiološke študije.
Immunological, toxicological and epidemiological studies shall be conducted.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 4 a (novo)
Annex 1, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 4 a (new)
– Uporaba znanstveno preskušene komplementarne in alternativne medicine.
– Use of scientifically tested complementary and alternative medicines.
Prepoznavanje uspešnih posegov komplementarne in alternativne medicine za izboljšanje zdravja evropskih državljanov.
To identify successful interventions in complementary and alternative medicine for improving the health of European citizens.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 4 b (novo)
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 4 b (new)
– Ustrezna uporaba novih tehnologij.
- Appropriate use of new technologies.
Zagotavljanje zmogljivosti za hiter razvoj in hitro proizvodnjo zdravstvenih protiukrepov za biološke grožnje in pojavljajoče se bolezni.
To provide capacity for fast development and rapid production of medical countermeasures to biological threats and emerging diseases.
Razumen prispevek genomskega inženiringa k boju proti pojavljajočim se epidemijam je deloma v hitrosti, ki jo zagotavlja pri razvoju zdravstvenih protiukrepov in biološko proizvedenih sevov.
Rational genome engineering’s contribution to fighting emerging epidemics lies partly in the speed it provides in the development of medical countermeasures and biological production strains.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 4 c (novo)
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 4 c (new)
– Nadnacionalna raziskava poklicnih bolezni in nesreč pri delu.
- Transnational research on occupational diseases and industrial accidents.
Za ustvarjanje in analizo podatkov o poklicnih bolezni in nesrečah pri delu, razvoj preventivnih, diagnostičnih strategij in strategij za zdravljenje (npr. v zvezi s kostno-mišičnimi boleznimi).
To generate and analyse the data relating to occupational diseases and industrial accidents, develop prevention, diagnostic and treatment strategies (e.g. in relation to musculoskeletal disorders).
Delo, opravljeno v okviru evropske socialne politike in socialnega dialoga, je pokazalo dodano vrednost skupnega pristopa k preprečevanju na področju poklicnih bolezni in nesreč pri delu.
The work carried out in the context of the European social policy and the Social Dialogue has demonstrated the added value of a common approach to prevention in the area of occupational diseases and industrial accidents.
Skupno politično usmeritev je treba krepiti tudi s podporo raziskovalnim dejavnostim za diagnozo in zdravljenje teh bolezni in nesreč.
It is necessary to strengthen this common policy upstream by also supporting research activities relating to the diagnosis and treatment of these diseases and accidents.
Priloga I, poglavje I Sodelovanje, tema 1 Zdravje, podnaslov Dejavnosti, zaporedna točka 3, alinea 4 d (novo)
Annex I, Chapter I "Cooperation", theme 1 "Health", subtitle "Activities", bullet 3, indent 4 d (new)
– Trajnostna optimizacija industrijskih procesov in učinkovin.
- Sustainable optimization of industrial processes and active ingredients
Optimizacija kemičnega (in fermentacijskega) dela proizvodnje učinkovin je potrebna za trajnost zdravstvenih tehnologij v gospodarstvu in okolju.
Optimization of the chemical (and fermentative) part of the active ingredients’ production is necessary for the economic and environmental sustainability of health technologies.
Priloga I, poglavje I Sodelovanje, tema 2 Prehrana, kmetijstvo in biotehnologija, podnaslov Cilj
Annex 1, Chapter I "Cooperation", theme 2 "Food, Agriculture and Biotechnology", subtitle "Objective"
Izgradnja na znanju temelječega evropskega bio gospodarstva preko povezovanja znanosti, industrije in drugih zainteresiranih strani, da bi izkoristili nove in nastajajoče raziskovalne možnosti, ki odgovarjajo na socialne in gospodarske izzive: naraščajoče povpraševanje po varnejši, bolj zdravi in bolj kakovostni hrani ter po trajnostni rabi in proizvodnji obnovljivih bioloških virov; naraščajoča nevarnost epizootskih in zoonotskih bolezni ter motenj, povezanih s prehrano; grožnje trajnosti in varnosti kmetijske in ribiške proizvodnje, ki so zlasti posledica podnebnih sprememb; ter naraščajoče povpraševanje po visokokakovostni hrani ob upoštevanju dobrega počutja živali in podeželskega okolja.
Building a European Knowledge Based Bio-Economy by bringing together science, industry and other stakeholders, to exploit new and emerging research opportunities that address social and economic challenges: the growing demand for safer, healthier and higher quality food and for sustainable use and production of renewable bio-resources; the increasing risk of epizootic and zoonotic diseases and food related disorders; threats to the sustainability and security of agricultural and and fisheries production resulting in particular from climate change; and the increasing demand for high quality food, taking into account animal welfare and rural contexts.
Izgradnja na znanju temelječega evropskega biogospodarstva prek povezovanja znanosti, industrije in drugih zainteresiranih strani, da bi podprli politike Unije in izkoristili nove in nastajajoče raziskovalne možnosti, ki odgovarjajo na socialne , okoljske in gospodarske izzive: naraščajoče povpraševanje po varnejši, bolj zdravi in bolj kakovostni hrani ter po trajnostni rabi , inženiringu in proizvodnji obnovljivih bioloških virov; naraščajoča nevarnost epizootskih in zoonotskih bolezni ter motenj, povezanih s prehrano; grožnje trajnosti in varnosti ribiške, ribogojske, kmetijske proizvodnje in živinoreje, skupaj s tistimi, ki so posledica zlasti podnebnih sprememb; ter naraščajoče povpraševanje po visokokakovostni hrani ob upoštevanju dobrega počutja živali in podeželskega in obalnega okolja ter načinov zadovoljevanja posebnih potreb potrošnikov .
Building a European Knowledge Based Bio- Economy by bringing together science, industry and other stakeholders, to support the Union's policies and to exploit new and emerging research opportunities that address social, environmental and economic challenges: the growing demand for safer, healthier and higher quality food and for sustainable use, engineering and production of renewable bio-resources; the increasing risk of epizootic and zoonotic diseases and food related disorders; threats to the sustainability and security of fisheries aquacultural, agricultural, and stockbreeding production, including those resulting in particular from climate change; and the increasing demand for high quality food, taking into account animal welfare and rural and coastal contexts and ways of meeting specific consumer needs.
Cilj raziskav bo vključiti različna znanstvena spoznanja za razvoj usklajenih, trajnostnih in družbeno sprejemljivih rešitev in pristopov.
Research will aim to integrate the diversity of scientific knowledge to develop balanced, sustainable and socially acceptable solutions and approaches.
Državljane je treba ozavestiti, da bodo imeli večjo možnost izbire na podlagi obveščanja.
The awareness of citizens will be pursued to improve their ability to make informed choices.
Priloga I, poglavje I Sodelovanje, tema 2 Prehrana, kmetijstvo in biotehnologija, podnaslov Utemeljitev, odstavek 1
Annex 1, Chapter I "Cooperation", theme 2 "Food, Agriculture and Biotechnology", subtitle "Rationale", paragraph 1
Inovacije in razvijanje znanja na področju trajnostnega gospodarjenja, proizvodnje in uporabe bioloških virov (mikroorganizmi, rastline, živali) bodo zagotovili osnovo za nove, trajnostne, ekološko učinkovite in konkurenčne proizvode za kmetijstvo, ribištvo, prehrambno, zdravstveno, gozdarsko in sorodne industrije.
Innovations and advancement of knowledge in the sustainable management, production and use of biological resources (micro-organism, plants, animals), will provide the basis for new, sustainable, eco-efficient and competitive products for agriculture, fisheries, food, health, forest based and related industries.
To bo v skladu z evropsko strategijo o znanosti o življenju in biotehnologiji pomagalo povečati konkurenčnost evropskih družb na področju biotehnologije in prehrane, zlasti visokotehnoloških MSP, ter ob tem izboljšati socialno varstvo in blaginjo.
In line with the European strategy on life sciences and biotechnogy, this will help increase the competitiveness of European biotechnology and food companies, in particular high tech SMEs, while improving social welfare and wellbeing.